Skip to main content
Premium Trial:

Request an Annual Quote

OraSure's DNA Genotek Gets FDA Clearance for Sample Collection Kits

NEW YORK – DNA Genotek, a wholly owned subsidiary of OraSure Technologies, said on Wednesday it has obtained 510(k) clearance from the US Food and Drug Administration for its Oragene Dx sample collection kits.

The Oragene Dx kits are used for the collection of saliva samples for DNA testing. The company noted in a statement that Oragene Dx is now the first and only device with general clearance for collection and stabilization of DNA from saliva for use in genetic testing of human germline DNA, "including prescription or over-the-counter, direct-to-consumer use." The kits also allow for long-term storage at room temperature of collected samples.

"With this 510(k) clearance genetic test providers offering diagnostic testing can confidently use our product within their test protocols without having to provide information on Oragene Dx devices in their FDA submissions," noted Kathleen Weber, executive vice president molecular solutions at the firm.

OraSure Technologies acquired Ottawa-based DNA Genotek in 2011 for $50.6 million.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more